Diabetes & Metabolism

Article	Citations
Contents - page 1	109
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France	98
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study	76
Editorial board	47
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department	39
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report	39
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?	37
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial	36
Editorial board	32
Contents	32
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	31
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants	31
Association between adipose deposition and mortality among adults without major cardiovascular risk factors	31
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework	29
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study	29
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps	28
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	27
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations	26
Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study	26
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021	26
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”	25
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	24
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review	24
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	23
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	22

Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020	22
Concise review of lipidomics in nonalcoholic fatty liver disease	20
Sommaire	19
Contents	19
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-2018	18
1-h post-load plasma glucose for detecting early stages of prediabetes	18
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study	18
Type B insulin resistance syndrome: A case report	17
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study	16
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability	16
Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)	16
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin	15
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT	15
Averaged glycaemic variability or by average: More than a simple question of wording	15
Contents	15
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes	14
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”	14
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study	14
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications	13
Glucose management indicator: Do we need device-specific equations?	13
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study	13
Editorial board	13
Diabetes prevalence, awareness, and control in the United States, 2017-2023	12
Editorial board	12
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	12
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	12
Conduction disturbances in Type 1 and Type 2 Diabetes in two large independent nationwide and international databases	12
Contents - Page 1	12
Transitions in metabolic health status over time and risk of heart failure: A prospective study	12
Peripheral neuropathy as a bedside marker for cerebral microangiopathy	12
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study	12
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy	11
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention	11
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease	11
Contents	11
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach	11
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes	11
Glucagon like peptide-1 receptor agonists in type 1 diabetes	11
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus	11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design	11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand	10
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders	10
Contents - page 1	10
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance	10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography	10
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis	10
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus	10
Editorial board	10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults	9
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus	9

One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals	9
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States	9
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	9
Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study	9
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report	9
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study	9
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs	9
Contents	9
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?	8
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists	8
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes	8
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION	8
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort	8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus	8
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan	8
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease	8
Editorial board	8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study	7
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 2019	7
Automated insulin delivery for people living with Type 1 Diabetes in France: A long road ahead	7
Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes	7
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	7
The progressive uncoupling of maternal insulin clearance and insulin sensitivity across gestation	7
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?	7
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	7
SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients	7
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch	7
Editorial board	7
Contents	7
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study	6
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	6
Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort	6
Patient-reported outcome measures (PROMs) are differently associated with treatment modalities, household income, and diabetes-related events in children with type 1 diabetes, their mothers, and their	6
Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry	6
Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study	6
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	6
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus	6
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study	6
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	6
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment	6
Trajectories of social isolation and loneliness and the risk of incident type 2 diabetes mellitus across genetic risk score	6
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey	5
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	5
Impaired auditory neural performance, another dimension of hearing loss in type-2 diabetes mellitus	5
Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)	5
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes	5
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study	5
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	5
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	5
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease	5
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity	5
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	5
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists	5
Editorial board	5
Epicardial adipose tissue measurement is an interesting biomarker for cardiovascular health in a case control study of patients with familial partial type 2 lipodystrophy	5
Contents	5
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring	5
Sommaire	5
Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study	5
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study	5
GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations	5
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease	5
Glucagon-like peptide-1 receptor agonists and acute pancreatitis	5
Microalbuminuria screening in patients with ST-elevation myocardial infarction	5
Editorial board	5
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study	5
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database	5
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review	5
Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss	4
Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study	4
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months	4
Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank	4
Early varicella infection is associated with a delayed onset of childhood type 1 diabetes	4
Management of patients with type 2 diabetes and MASLD: An overview and joint statement	4
Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series	4
Editorial board	4
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study	4
Overweight and risk of type 2 diabetes: A prospective Chinese twin study	4
Editorial board	4
Comment on Orsi et al. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes [Diabetes Metab, 2023 Mar, 101413]	4

Self-reported haemoglobin A1c highly agrees with laboratory-measured haemoglobin A1c among adults living with type 1 diabetes: A BETTER registry study	4
Key indices of glycaemic variability for application in diabetes clinical practice	4
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	4
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study	4
Editorial board	4
Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study	4
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks	4
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies	4
Smoking and diabetes interplay: A comprehensive review and joint statement	3
Contents	3
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	3
Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study	3
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes	3
Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: A case series	3
The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study	3
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society	3
Variable incidence of ketoacidosis in youth with type 1 diabetes onset during COVID-19 pandemic peaks in France	3
Practical implementation of automated insulin delivery systems in 2025: A French position statement update	3
Contents	3
Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study	3
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease	3
Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort	3